This November, voters will have the opportunity to vote yes on Proposition 14 to authorize $5.5 billion in state general obligation bonds to continue the advancement of treatments and cures here in
In September, the Centers for Medicare and Medicaid Services (CMS) released a proposed rule (CMS-3372-P) entitled “Medicare Coverage of Innovative Technology (MCIT) and Definition of ‘Reasonable and Necessary’”.
The new Fiscal Year (FY) will begin at midnight tonight on October 1st. At the time this update was prepared on September 29th, a government shutdown is unlikely following the House passage of a continuing resolution (CR) to fund the government at FY20 levels through December 11, 2020.
On Friday, September 25th, Governor Newsom signed AB 713 a measure introduced by Assembly member Kevin Mullin (D-South San Francisco).
CLSA is profoundly disappointed by the Administration’s decision to move forward with the flawed concept of a ‘Most Favored Nation’ policy that threatens the innovative life sciences ecosystem and patient access to cutting edge biomedical advancement.
On Wednesday September 9th, the California Supreme Court refused to hear a case brought forward by the Howard Jarvis Taxpayers Association, the California Business Roundtable and the California Business Properties Association regarding whether only a simple majority versus a supermajority vote was necessary to pass a San Francisco corporate tax ballot measure which passed in 2018.
While much of the attention in November’s election is focused on the race for President, Californians are going to have a lot of other decisions to make, including statewide ballot measures.
A member of the Senate tested positive, requiring the entire body to be tested and cleared before they could safely continue their work.
CLSA has long supported efforts to combat AMR, and in a continuation of efforts to expand the coalition of organizations that CLSA engages with on important issues, we agreed to join 14 other cosigners on the letters.
President Trump officially signed four Executive Orders (EOs) last Friday. The EOs target four policy areas: drug importation, 340B, rebate rule, and most concerning – IPI/Most Favored Nation (MFN).